Science Explorer Back to mapMap
Researcher · Texas Oncology · United States

Des Ilegbodu

Des Ilegbodu publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Cancer Research, on topics such as Cancer Treatment and Pharmacology, Lung Cancer Treatments and Mutations and Breast Cancer Treatment Studies.

OpenAlex
World rank
#4,036,114
of 7,710,434 ranked researchers
Rank in United States
#1,098,952
of 1,627,098
Works
33
Citations
950
Citations per work
28.8
h-index
13
i10-index 16Top 44% in Oncology

What does Des Ilegbodu research?

Des Ilegbodu's work is mostly in Medicine (79%), Biochemistry, Genetics and Molecular Biology (7%).

Life Sciences7%Health Sciences79%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2678.6%
  1. Everything else514.3%
    1. Biochemistry, Genetics and Molecular Biology27.1%
  1. 1Oncology39% of their works
  2. 2Pulmonary and Respiratory Medicine26% of their works
  3. 3Cancer Research7% of their works
  4. 4Surgery5% of their works
  5. 5Hepatology5% of their works
  6. 6Dermatology3% of their works

Research topics

Which keywords describe Des Ilegbodu's research?

The keywords of their largest research topics: Chemotherapy-Induced Peripheral Neuropathy, Taxanes, Chemotherapy, EGFR Mutations, Targeted Therapy, Molecular Subtypes, Clinical Practice Guidelines and Radiotherapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Chemotherapy-Induced Peripheral Neuropathy191 topic
  2. Taxanes191 topic
  3. Chemotherapy143 topics
  4. EGFR Mutations141 topic
  5. Targeted Therapy141 topic
  6. Molecular Subtypes132 topics
  7. Clinical Practice Guidelines122 topics
  8. Radiotherapy112 topics
  9. Breast Cancer72 topics
  10. Breast Tumours71 topic
  11. Gene Expression71 topic
  12. Cetuximab61 topic
  13. KRAS Mutations61 topic
  14. Hepatocellular Carcinoma51 topic
  15. Liver Cancer51 topic
  16. CT Screening41 topic
  17. HER241 topic
  18. Lung Cancer41 topic
  19. Trastuzumab41 topic
  20. Estrogen31 topic
  21. Receptor31 topic

Where does Des Ilegbodu work?

Des Ilegbodu's main affiliation in the publication record is Texas Oncology, United States.

How many publications and citations does Des Ilegbodu have?

OpenAlex counts 33 works and 950 citations for Des Ilegbodu, an h-index of 13, ranking #4,036,114 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Des Ilegbodu. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.